GR3034188T3 - Treatment of migraine - Google Patents

Treatment of migraine

Info

Publication number
GR3034188T3
GR3034188T3 GR20000401882T GR20000401882T GR3034188T3 GR 3034188 T3 GR3034188 T3 GR 3034188T3 GR 20000401882 T GR20000401882 T GR 20000401882T GR 20000401882 T GR20000401882 T GR 20000401882T GR 3034188 T3 GR3034188 T3 GR 3034188T3
Authority
GR
Greece
Prior art keywords
migraine
blocking agent
treatment
administered
relates
Prior art date
Application number
GR20000401882T
Other languages
English (en)
Inventor
Arthur M Goldberg
Leonard Lachman
Original Assignee
Ribogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribogene Inc filed Critical Ribogene Inc
Publication of GR3034188T3 publication Critical patent/GR3034188T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Disintegrating Or Milling (AREA)
  • Catalysts (AREA)
  • Medicines Containing Plant Substances (AREA)
GR20000401882T 1992-03-13 2000-08-14 Treatment of migraine GR3034188T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/850,566 US5242949A (en) 1992-03-13 1992-03-13 Treating classic migraine
PCT/US1993/002132 WO1993017672A1 (en) 1992-03-13 1993-03-08 Treatment of migraine

Publications (1)

Publication Number Publication Date
GR3034188T3 true GR3034188T3 (en) 2000-11-30

Family

ID=25308498

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401882T GR3034188T3 (en) 1992-03-13 2000-08-14 Treatment of migraine

Country Status (18)

Country Link
US (1) US5242949A (el)
EP (1) EP0727986B1 (el)
JP (1) JP2839207B2 (el)
KR (1) KR950701215A (el)
AT (1) ATE193441T1 (el)
AU (1) AU675931B2 (el)
CA (1) CA2131991C (el)
DE (1) DE69328792T2 (el)
DK (1) DK0727986T3 (el)
ES (1) ES2148222T3 (el)
FI (1) FI944236A (el)
GR (1) GR3034188T3 (el)
HU (1) HUT71834A (el)
MX (1) MX9301393A (el)
NO (1) NO943372L (el)
PH (1) PH30101A (el)
PT (1) PT727986E (el)
WO (1) WO1993017672A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408026A (en) * 1993-08-23 1995-04-18 Cowan; Patrick J. Curable and cured organosilicon compositions, and process for making same
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20080226715A1 (en) * 2007-03-16 2008-09-18 Albert Cha Therapeutic compositions and methods
WO2009103150A1 (en) * 2008-02-20 2009-08-27 Kevin David Smith Method for treating migraine headaches
US9399053B2 (en) 2011-07-22 2016-07-26 The University Of Chicago Treatments for migraine and related disorders
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394390A (en) * 1979-08-03 1983-07-19 University Of Kentucky Research Foundation Nasal dosage forms of propranol
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same

Also Published As

Publication number Publication date
HU9402612D0 (en) 1994-11-28
PT727986E (pt) 2000-11-30
JPH08500329A (ja) 1996-01-16
DE69328792D1 (de) 2000-07-06
DE69328792T2 (de) 2001-02-01
HUT71834A (en) 1996-02-28
ATE193441T1 (de) 2000-06-15
CA2131991C (en) 1999-07-06
FI944236A0 (fi) 1994-09-13
NO943372L (no) 1994-11-14
DK0727986T3 (da) 2000-10-30
EP0727986A4 (en) 1995-04-25
PH30101A (en) 1996-12-27
EP0727986B1 (en) 2000-05-31
KR950701215A (ko) 1995-03-23
WO1993017672A1 (en) 1993-09-16
NO943372D0 (no) 1994-09-12
FI944236A (fi) 1994-11-11
US5242949A (en) 1993-09-07
MX9301393A (es) 1994-08-31
EP0727986A1 (en) 1996-08-28
AU3799193A (en) 1993-10-05
ES2148222T3 (es) 2000-10-16
AU675931B2 (en) 1997-02-27
CA2131991A1 (en) 1993-09-16
JP2839207B2 (ja) 1998-12-16

Similar Documents

Publication Publication Date Title
TW200607512A (en) Use of optically pure (S,S)-reboxetine in the manufacture of a medicament for the treatment or prevention of migraine headaches
GR3030418T3 (en) Method and compositions for the treatment of cerebral palsy.
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
MY113059A (en) Controlled-release dosage forms of azithromycin
PL309398A1 (en) Interferon containing therapeutic composition
HU9700056D0 (en) New pharmaceutical composition for treating pains
NO961478D0 (no) Levobupivacaine anvendelig for kontroll av kronisk smerte
GR3034188T3 (en) Treatment of migraine
BG106461A (en) Methods and use of rapid onset of reactive serotonin inhibitors for treating sexual dysfunction
BG104092A (en) Cd154 blockade therapy for the treatment of protein inhibition syndrome
SE9601395D0 (sv) New therapeutic treatment 1
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
PT1076561E (pt) Terapia de combinacao para o tratamento de tumores
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
PL349889A1 (en) Method for treatment of headache
WO2001042205A3 (en) Treatment of inflammatory bowel disease with vitamin d compounds
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO995539D0 (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer
WO1998025594A3 (en) Lamotrigine in the treatment and prophylaxis of migraine
NO984190L (no) FremgangsmÕte for behandling av insomnia
NO981020D0 (no) Transdermalt terapautisk system for silatranforbindelser
UA50329A (uk) Спосіб лікування первинної бешихи
UA33498A (uk) Спосіб лікування терапевтично резистентних форм шизофренії
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией
UA10257A (uk) Спосіб фізіотерапевтичного впливу на організм людини

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees